洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong

【ChiCTR2600118222】A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong

查看原文
立即下载
基本信息
登记号

ChiCTR2600118222

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-02-03

临床申请受理号

/

靶点

/

适应症

Diabetes Mellitus

试验通俗题目

A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong

试验专业题目

A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

1.Comparing with the control group (CG) receiving conventional didactic information, the IPE-SDT intervention group shows significant improvement on HbA1C levels. 2.The utilisation of public medical resources including accident & emergency room visit, clinic visit, and hospital admissions for diabetes-related matters in the IPE-SDT intervention group will be less than the CG. 3.The SDT-IPE educational intervention has positive effect on subjects’ psychological factors of perceived autonomy, competency, and relatedness that can result in changes in their motivation and engagement and lead to changes in health behaviours that could impact on their health status (both physical and psychological well-being) after they have received the 3-month educational program.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

The current study adopted the RCT study design. Eligible students will be randomly assigned (1:1) with a computer-generated list of random numbers to one of the two groups.

盲法

N/A

试验项目经费来源

General Research Fund (GRF), University Grants Committee, Hong Kong

试验范围

/

目标入组人数

80

实际入组人数

/

第一例入组时间

2025-01-01

试验终止时间

2027-06-30

是否属于一致性

/

入选标准

1. All male or female Chinese newly diagnosed DM subjects aged between 45-70 years old; 2. Able to give informed consent.；

排除标准

1. Patients who have dementia and/or cannot understand Cantonese; 2. Patients who have gestational diabetes; 3. Concurrently involved in another clinical trial, educational/behavioural modification intervention program；

研究者信息
研究负责人姓名
请登录查看
试验机构

General Research Fund (GRF), University Grants Committee, Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

General Research Fund (GRF), University Grants Committee, Hong Kong的其他临床试验

更多

The Nethersole School of Nursing The Chinese University of Hong Kong的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品

同适应症药物临床试验

更多